Literature DB >> 20975683

USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis.

Annette Aichem1, Christiane Pelzer, Sebastian Lukasiak, Birte Kalveram, Paul W Sheppard, Neha Rani, Gunter Schmidtke, Marcus Groettrup.   

Abstract

The ubiquitin-like modifier FAT10 targets proteins for degradation by the proteasome and is activated by the E1 enzyme UBA6. In this study, we identify the UBA6-specific E2 enzyme (USE1) as an interaction partner of FAT10. Activated FAT10 can be transferred from UBA6 onto USE1 in vitro, and endogenous USE1 and FAT10 can be coimmunoprecipitated from intact cells. Small interfering RNA-mediated downregulation of USE1 mRNA resulted in a strong reduction of FAT10 conjugate formation under endogenous conditions, suggesting that USE1 is a major E2 enzyme in the FAT10 conjugation cascade. Interestingly, USE1 is not only the first E2 enzyme but also the first known substrate of FAT10 conjugation, as it was efficiently auto-FAT10ylated in cis but not in trans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20975683     DOI: 10.1038/ncomms1012

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  30 in total

1.  A MHC-encoded ubiquitin-like protein (FAT10) binds noncovalently to the spindle assembly checkpoint protein MAD2.

Authors:  Y C Liu; J Pan; C Zhang; W Fan; M Collinge; J R Bender; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

2.  Molecular insights into polyubiquitin chain assembly: crystal structure of the Mms2/Ubc13 heterodimer.

Authors:  A P VanDemark; R M Hofmann; C Tsui; C M Pickart; C Wolberger
Journal:  Cell       Date:  2001-06-15       Impact factor: 41.582

3.  The basis for selective E1-E2 interactions in the ISG15 conjugation system.

Authors:  Larissa A Durfee; Melissa L Kelley; Jon M Huibregtse
Journal:  J Biol Chem       Date:  2008-06-26       Impact factor: 5.157

Review 4.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

5.  Identification of seven new human MHC class I region genes around the HLA-F locus.

Authors:  W Fan; W Cai; S Parimoo; D C Schwarz; G G Lennon; S M Weissman
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

6.  The UBA domains of NUB1L are required for binding but not for accelerated degradation of the ubiquitin-like modifier FAT10.

Authors:  Gunter Schmidtke; Birte Kalveram; Elvira Weber; Petra Bochtler; Sebastian Lukasiak; Mark Steffen Hipp; Marcus Groettrup
Journal:  J Biol Chem       Date:  2006-05-17       Impact factor: 5.157

7.  The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein.

Authors:  Chen Zhao; Sylvie L Beaudenon; Melissa L Kelley; M Brett Waddell; Weiming Yuan; Brenda A Schulman; Jon M Huibregtse; Robert M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-06       Impact factor: 11.205

8.  Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging.

Authors:  Jianping Jin; Xue Li; Steven P Gygi; J Wade Harper
Journal:  Nature       Date:  2007-06-28       Impact factor: 49.962

9.  Role of ubiquitin-like protein FAT10 in epithelial apoptosis in renal disease.

Authors:  Michael J Ross; Matthew S Wosnitzer; Michael D Ross; Benedetta Granelli; G Luca Gusella; Mohammad Husain; Lewis Kaufman; Matthew Vasievich; Vivette D D'Agati; Patricia D Wilson; Mary E Klotman; Paul E Klotman
Journal:  J Am Soc Nephrol       Date:  2006-02-22       Impact factor: 10.121

10.  Activation of the heat-stable polypeptide of the ATP-dependent proteolytic system.

Authors:  A Ciechanover; H Heller; R Katz-Etzion; A Hershko
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

View more
  34 in total

1.  Alternative ubiquitin activation/conjugation cascades interact with N-end rule ubiquitin ligases to control degradation of RGS proteins.

Authors:  Peter C W Lee; Mathew E Sowa; Steven P Gygi; J Wade Harper
Journal:  Mol Cell       Date:  2011-08-05       Impact factor: 17.970

Review 2.  Post-translational modification and protein sorting to small extracellular vesicles including exosomes by ubiquitin and UBLs.

Authors:  Hiroshi Ageta; Kunihiro Tsuchida
Journal:  Cell Mol Life Sci       Date:  2019-07-30       Impact factor: 9.261

3.  A USE1ful Biomarker and Molecular Target in Lung Cancer?

Authors:  Wanping Xu; Len Neckers
Journal:  J Natl Cancer Inst       Date:  2016-10-21       Impact factor: 13.506

4.  The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1.

Authors:  Johanna Bialas; Annika N Boehm; Nicola Catone; Annette Aichem; Marcus Groettrup
Journal:  J Biol Chem       Date:  2019-02-04       Impact factor: 5.157

5.  Extended lifespan and reduced adiposity in mice lacking the FAT10 gene.

Authors:  Allon Canaan; Jason DeFuria; Eddie Perelman; Vincent Schultz; Montrell Seay; David Tuck; Richard A Flavell; Michael P Snyder; Martin S Obin; Sherman M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-24       Impact factor: 11.205

6.  Ubiquitin-like protein MNSFβ noncovalently binds to molecular chaperone HSPA8 and regulates osteoclastogenesis.

Authors:  Kaori Notsu; Mai Nakagawa; Morihiko Nakamura
Journal:  Mol Cell Biochem       Date:  2016-09-01       Impact factor: 3.396

7.  The FAT10 post-translational modification is involved in the lytic replication of Kaposi's sarcoma-associated herpesvirus.

Authors:  Atsuko Sugimoto; Yuichi Abe; Tadashi Watanabe; Kohei Hosokawa; Jun Adachi; Takeshi Tomonaga; Yasumasa Iwatani; Takayuki Murata; Masahiro Fujimuro
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

8.  Altered social behavior and neuronal development in mice lacking the Uba6-Use1 ubiquitin transfer system.

Authors:  Peter C W Lee; Jean-Cosme Dodart; Liviu Aron; Lydia W Finley; Roderick T Bronson; Marcia C Haigis; Bruce A Yankner; J Wade Harper
Journal:  Mol Cell       Date:  2013-03-14       Impact factor: 17.970

9.  Profiling of ubiquitin-like modifications reveals features of mitotic control.

Authors:  Yifat Merbl; Phillipe Refour; Hevan Patel; Michael Springer; Marc W Kirschner
Journal:  Cell       Date:  2013-02-28       Impact factor: 41.582

10.  ELK1 transcription factor linked to dysregulated striatal mu opioid receptor signaling network and OPRM1 polymorphism in human heroin abusers.

Authors:  Stephanie E Sillivan; John D Whittard; Michelle M Jacobs; Yanhua Ren; Amin R Mazloom; Francesca F Caputi; Monika Horvath; Eva Keller; Avi Ma'ayan; Ying-Xian Pan; Lillian W Chiang; Yasmin L Hurd
Journal:  Biol Psychiatry       Date:  2013-05-20       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.